Free Trial

Summit Therapeutics (SMMT) SEC Filings & 10K Form

Summit Therapeutics logo
$18.31 -1.14 (-5.86%)
(As of 11/15/2024 ET)

Recent Summit Therapeutics SEC Filings

DateFilerForm TypeView
10/30/2024
6:33 AM
Summit Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/30/2024
6:06 AM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/15/2024
4:08 PM
Clark Kenneth A (Reporting)
Summit Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
3:54 PM
Summit Therapeutics (Issuer)
Zanganeh Mahkam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/19/2024
4:28 PM
Summit Therapeutics (Filer)
Form S-3ASR
09/13/2024
6:29 PM
Summit Therapeutics (Issuer)
Zanganeh Mahkam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2024
5:25 PM
DUGGAN ROBERT W (Reporting)
Summit Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2024
4:54 PM
DUGGAN ROBERT W (Filed by)
Summit Therapeutics (Subject)
Form SC 13D/A
09/13/2024
4:40 PM
Huber Jeff (Reporting)
Summit Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2024
4:26 PM
Anand Bhaskar (Reporting)
Summit Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2024
4:29 PM
Soni Manmeet Singh (Reporting)
Summit Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2024
5:49 AM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/09/2024
6:23 AM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2024
6:14 AM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2024
6:37 AM
Summit Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/27/2024
4:20 PM
Huber Jeff (Reporting)
Summit Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
4:16 PM
Huber Jeff (Reporting)
Summit Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/27/2024
3:27 PM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/18/2024
4:14 PM
Summit Therapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
06/17/2024
4:25 PM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/13/2024
1:03 PM
Summit Therapeutics (Filer)
Form DEFA14A
06/03/2024
5:18 AM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/03/2024
5:05 AM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/30/2024
3:48 PM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/24/2024
7:35 AM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2024
7:03 AM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2024
6:48 AM
Summit Therapeutics (Filer)
Form 424B5
05/01/2024
7:45 AM
Summit Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/01/2024
7:18 AM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/01/2024
7:11 AM
Summit Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/15/2024
8:21 AM
Ronaghi Mostafa (Reporting)
Summit Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2024
8:19 AM
Ronaghi Mostafa (Reporting)
Summit Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
04/11/2024
3:35 PM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/04/2024
4:52 PM
Soni Manmeet Singh (Reporting)
Summit Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2024
4:43 PM
Anand Bhaskar (Reporting)
Summit Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
04/04/2024
4:47 PM
Anand Bhaskar (Reporting)
Summit Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2024
3:42 PM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/27/2024
7:27 PM
Dhingra Ankur (Reporting)
Summit Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2024
7:28 PM
Summit Therapeutics (Issuer)
Zanganeh Mahkam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/22/2024
7:07 AM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/12/2024
7:36 AM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
2024's Must-Watch Stocks! (Ad)

Welcome to a year of unparalleled opportunities! Dive into our exclusive guide, "9 Stocks Set to Soar," meticulously selected to elevate your portfolio in 2024. Step into 2024 with confidence and the right assets at your fingertips. Click below to opt-in and receive up to two additional free bonus subscriptions. Unsubscribe at any time.

02/27/2024
11:15 PM
Summit Therapeutics (Filer)
Form EFFECT
02/20/2024
6:55 AM
Summit Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
02/20/2024
7:05 AM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/20/2024
6:32 AM
Summit Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/15/2024
4:25 PM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
3:35 PM
Summit Therapeutics (Issuer)
Xia Yu (Reporting)
Form 5
Annual statement of changes in beneficial ownership of securities  
02/08/2024
3:08 PM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2024
8:07 AM
Summit Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/04/2024
3:19 PM
Summit Therapeutics (Issuer)
Xia Yu (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
3:22 PM
Mahatme Ujwala (Reporting)
Summit Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
3:24 PM
Clark Kenneth A (Reporting)
Summit Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
3:16 PM
DUGGAN ROBERT W (Reporting)
Summit Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2023
4:11 PM
Summit Therapeutics (Issuer)
Zanganeh Mahkam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2023
3:49 PM
Dhingra Ankur (Reporting)
Summit Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:SMMT) was last updated on 11/17/2024 by MarketBeat.com Staff
From Our Partners